http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d3a87dd3c516b29d35e8c9ed16f0b7ff
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Fernandez-Zapico |
| name | Martin E Fernandez-Zapico Martin E. Fernandez-Zapico |
| given-name | Martin E Martin E. |
| organization-name | Schulze Center for Novel Therapeutics, Mayo Clinic, Rochester, MN 55905; †Schulze Center for Novel Therapeutics, Mayo Clinic, Rochester, MN 55905 Schulze Center for Novel Therapeutics, Mayo Clinic, MN, USA 2GI Research Unit, Mayo Clinic College of Medicine, Rochester, Minnesota Gonda Department of Cell and Molecular Biology, House Ear Institute, Los Angeles, CA 90057; Gastroenterology Research Unit, Mayo Clinic College of Medicine, Rochester, MN 55905; Children's Hospital at Montefiore and Albert Einstein College of Medicine, Bronx, NY 10461; and Departments of Otolaryngology and Cell and Neurobiology, University of Southern California, Los Angeles, CA 90089 4Schulze Center for Novel Therapeutics, Mayo Clinic, Rochester, Minnesota. Centre National de la Recherche Scientifique, Unité Mixte de Recherche 8090, Institute of Biology, Institute Pasteur de Lille, F-59019 Lille, France; Gastroenterology Research Unit, Saint Mary's Hospital, Mayo Clinic, Rochester, MN 55905; Department of Endocrinology and Metabolism, Hadassah University Hospital, Jerusalem 91120, Israel; Steno Diabetes Center and Hagedorn Research Institute, DK-2820 Copenhagen, Denmark; Molecular Nutrition Unit, Centre de Recherche du Centre Hospitalier l'Université... 3Division of Oncology Research, Schulze Center for Novel Therapeutics, Mayo Clinic, Rochester, Minnesota. 1Schulze Center for Novel Therapeutics, Division of Oncology Research, Department of Oncology, Mayo Clinic, Rochester, Minnesota. Authors' Affiliations: 1Institute of Molecular Biology and Tumor Research (IMT), Philipps University, Marburg, Germany; 2Schulze Center for Novel Therapeutics, Division of Oncology Research; and 3Department of Medical Oncology, Mayo Clinic, Rochester, Minnesota 2Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine and Science, Rochester, Minnesota.; 4Schulze Center for Novel Therapeutics, Mayo Clinic, Rochester, Minnesota. 2Schulze Center for Novel Therapeutics, Division of Oncology Research, Mayo Clinic, Rochester, Minnesota. Schulze Center for Novel Therapeutic, Division of Oncology Research (E.J.T., M.E.F.-Z.), Mayo Clinic, Rochester, MN. Authors' Affiliations: 1Signaling and Transcription Laboratory, Department of Gastroenterology, Philipps University, Marburg; 2Department of Gastroenterology and Gastrointestinal Oncology, University Medical Center Göttingen, Göttingen; 3II. Medizinische Klinik, Klinikum rechts der Isar, Technische Universität; 4Institute of Pathology, Helmholtz Zentrum, Munich; 5Theodor Boveri Institute, University of Würzburg, Würzburg; 6Institute for Genetics, Justus-Liebig-University, Giessen, Germany; 7Schulze Center for Novel Therapeutics, Division of Oncology Research; Divisions of 8Anatomic Pathology and 9Biostatistics, College of Medicine; 10Laboratory of Epigenetics and Chromatin Dynamics, Department of Medicine, Biochemistry and Molecular Biology, Mayo Clinic, Rochester, Minnesota; 11Barrow Brain Tumor Research Center, St. Joseph's Hospital and Medical Center, Phoenix, Arizona; and 12Cold Spring Harbor Laboratory, Cold Spring Harbor, New York Gastroenterology Research Unit, Mayo Clinic College of Medicine, Rochester, MN Authors' Affiliations: 1Cancer Biology Program, 2Department of Biochemistry and Molecular Biology, 3Division of Pediatric Research, and 4Schulze Center for Novel Therapeutics, Mayo Clinic College of Medicine, Rochester, Minnesota; and 5Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, Kansas 2Gastrointestinal Unit, 7Department of Oncology, Mayo Clinic, Rochester, Minnesota.; 8Schulze Center for Novel Therapeutics, Mayo Clinic, Rochester, Minnesota. Gastroenterology Research Unit, Saint Mary's Hospital, Mayo Clinic, Rochester, MN 55905, USA. David L. Marks, Tara L. Hogenson, Anne M. Vrabel, Ashley N. Sigafoos, Ezequiel J. Tolosa, Ryan M. Carr, Stephanie L. Safgren, Elisa Enriquez Hesles, Luciana L. Almada, Paola A. Romecin-Duran, Eriko Iguchi, Aryan Ala’Aldeen, Jean-Pierre A. Kocher, Gavin R. Oliver, Naresh Prodduturi, David W. Mead, Asif Hossain, Norine E. Huneke, Colleen M. Tagtow, Sikander Ailawadhi, Stephen M. Ansell, Michaela S. Banck, Asher A. Chanan-Khan, Ronald S. Go, Thorvardur R. Halfdanarson, Richard W. Joseph, Prashant Kapoor,... 14Schulze Center for Novel Therapeutics, Division of Oncology Research, Mayo Clinic, Rochester, Minnesota. Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine, Rochester, MN 55901, U.S.A.; Schulze Center for Novel Therapeutics, Mayo Clinic College of Medicine, Rochester, MN 55901, U.S.A. Schulze Center for Novel Therapeutics, Division of Oncology Research, Mayo Clinic, Rochester, MN, USA Schulze Center for Novel Therapeutics, Division of Oncology Research, Mayo Clinic, Rochester, MN 55905; Authors' Affiliations: 1Inserm U1053; 2University of Bordeaux; 3Inserm U1029; Departments of 4Pathology and 5Neurosurgery, CHU Pellegrin, Bordeaux, France; 6McGill Centre for Bioinformatics, McGill University, Montreal, Quebec, Canada; and Departments of 7Radiation Oncology, 8Biostatistics, 9Anatomic Pathology and Laboratory Medicine, and 10Center for Novel Therapeutics, Mayo Clinic, Rochester, Minnesota Schulze Center for Novel Therapeutics, Division of Oncology Research, Mayo Clinic, Rochester, Minnesota. Department of Molecular Pharmacology and Experimental Therapeutics and; Department of Oncology, Mayo Clinic, Rochester, MN;; Department of Medicine and; Department of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, MN Schulze Center for Novel Therapeutics, Division of Oncology Research, and Schulze Center for Novel Therapeutics, Mayo Clinic, Rochester, MN 55905, USA †Gastroenterology Research Unit, and abh Mayo Clinic, Schulze Center for Novel Therapeutics, Division of Oncology Research , Department of Oncology , Rochester , MN , USA. 2Schulze Center for Novel Therapeutics, Mayo Clinic, Rochester, Minnesota. Schulze Center for Novel Therapeutics, Division of Oncology Research, Medical Oncology, Mayo Clinic, Rochester, MN, U.S.A Schulze Center for Novel Therapeutics, Division of Oncology Research, Mayo Clinic, Rochester, Minnesota, USA Schulze Center for Novel Therapeutics and |
Incoming Links
Total number of triples: 169.